tween 1915 and 1928. To our knowledge, although a viral etiology has long been suspected in EL, no infectious agent has ever been isolated.
The mechanism underlying viral SN tropism is not known. Nonetheless, collectively these cases support the hypothesis that viral infection of the SN can produce parkinsonism, and some have argued that viruses may be one of many environmental causes of nigrostriatal degeneration resulting in the subsequent development of idiopathic Parkinson disease.
1,2
Report of a Case | A previously healthy woman in her 30s with no recent travel history presented to an outside facility with a 6-day history of left otalgia, headache, fever, and neck stiffness. Her body temperature was 38.9°C, but her neurologic examination results were reportedly normal. Cerebrospinal fluid analysis revealed an elevated protein level with associated lymphocytic pleocytosis; polymerase chain reaction results were positive for enterovirus (Table) . Four days following admission, she developed progressive asymmetric (left > right) quadriparesis with rigidity and a fluctuating level of alertness. Magnetic resonance imaging (MRI) of the brain demonstrated symmetrical T2 signal change extending from the midbrain caudally to the dorsal pons ( Figure) . Given continued deterioration in the intervening days, transfer to our institution was recommended. Six days prior to transfer, she was treated with a course of intravenous immunoglobulins and began treatment with carbidopa, 12.5 mg, and levodopa, 50 mg, 3 times daily.
At transfer 2 weeks after initial presentation, the patient was alert but her speech was hypokinetic. She had ocular flutter and marked rigidity, left greater than right, in all 4 limbs. Repeated MRI showed overall improvement but interval maturation of the signal change in the SN, right greater than left ( Figure) . Dopamine transporter scan demonstrated reduced tracer uptake in the right striatum (Figure) . Ongoing levodopa therapy resulted in near resolution of her parkinsonism and was discontinued a few months after discharge.
Evaluation at 1 year revealed cogwheel rigidity, bradykinesia, and rest tremor in her left upper extremity. She also reported intermittent dystonic posturing of her left foot. Repeated MRI showed gliotic changes in the right SN (Figure) . Dopamine transporter scan demonstrated reduced uptake in the putamen, right greater than left (Figure) . She is currently undergoing a treatment trial with ropinirole hydrochloride.
Discussion | To our knowledge, this is the first report of viral postencephalitic parkinsonism demonstrating radiographic evidence of impaired dopaminergic presynaptic function. Positron emission tomography with fluorine F 18-labeled fluorodopa has been performed on patients with both pandemic-associated and sporadic EL, with results comparable to those of patients with Parkinson disease.
5 Although diagnostic criteria exist for EL, the scope of the disorder remains ill defined and it is unclear whether all cases of EL share the same etiology or even whether EL is a distinct nosological entity.
5,6
Consequently, the role of infection in this disorder remains hypothetical.
The patient presented with levodopa-responsive parkinsonism in the setting of enteroviral encephalitis. Initial MRI showed diffuse brainstem signal change, but repeated imaging over a year demonstrated asymmetrical destructive changes in the SN (right > left). Functional imaging showed persistent changes in the striatum. Although the patient's parkinsonism is currently static, it remains to be seen whether it progresses along the lines of Parkinson disease.
Michel Toledano, MD Nicholas W. S. Davies, PhD, FRCP 
COMMENT & RESPONSE Proton Pump Inhibitors and Dementia Incidence
To the Editor Dietary aluminum ingestion is theorized to be neurotoxic and play a causative role in the onset and progression of dementia. 1-3 A recent meta-analysis showed that individuals chronically exposed to aluminum were 71% more likely to develop Alzheimer disease (odds ratio, 1.71; 95% CI, 1.35-2.18).
4
Many strong antacids contain aluminum hydroxide and are often taken for years by patients with peptic ulcer disease or gastroesophageal reflux before they are prescribed proton pump inhibitors, and concurrent with their use. Gomm and colleagues 5 do not correct for the use of aluminum-containing antacids when calculating the association of dementia with proton pump inhibitor use. How much of their observed association of proton pump inhibitor use with dementia is actually due to long-term ingestion of aluminum antacids, either currently or in the past?
David Louis Keller, MD
Author Affiliation: Lomita, California. To the Editor I read with interest the article by Gomm and colleagues, 1 which examined the association between the use of proton pump inhibitors (PPIs) and incident dementia in elderly individuals in a prospective study. The authors adopted timedependent Cox regression analysis, and the time-dependent covariates were polypharmacy and the comorbidities of depression, diabetes, ischemic heart disease, and stroke. Age and sex were also used as confounding factors. The hazard ratio of PPIs for incident dementia was 1. that not only PPIs but also histamine-2 receptor antagonists were significantly associated with the presence of vitamin B 12 deficiency. Relating to this fact, Gray et al 5 examined the association between histamine-2 receptor antagonist medications and incident all-cause dementia or Alzheimer disease using a prospective study in 2923 participants aged 65 and older without dementia at baseline. They concluded that there was no significant association between histamine-2 receptor antagonist use and all-cause dementia or Alzheimer disease. Further studies are needed to confirm the biological mechanism on the association between the use of PPIs and incident dementia.
Tomoyuki Kawada, MD
Author Affiliation: Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan.
